Market Tracker

08/17 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

39.71
Delayed Data
As of 3:59pm ET
 -1.56 / -3.78%
Today’s Change
26.16
Today|||52-Week Range
46.81
+28.84%
Year-to-Date

Today’s Trading

Previous close41.27
Today’s open41.02
Day’s range39.69 - 41.18
Volume267,537
Average volume (3 months)323,679
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio77.9
Price/Sales10.05
Price/Book8.28

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.20-2.23%
LXRXLexicon Pharmaceutic...-0.16-1.10%
PCRXPacira Pharmaceutica...-1.10-2.96%
MYOKMyoKardia Inc+0.80+1.87%
Data as of 4:00pm ET, 08/17/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts